New Zealand Herpes Foundation's Groundbreaking Campaign Wins Prestigious Cannes Lions Grand Prix For Good
Press Release – NZ Herpes Foundation
The New Zealand Herpes Foundation (NZHF) is proud to announce that its pioneering 'Make New Zealand the Best Place in the World to Have Herpes' campaign has been awarded the Lions Health and United Nations Foundation Grand Prix for Good at the 2025Cannes Lions International Festival of Creativity – one of the most prestigious awards in global advertising and creative excellence.
The campaign, developed in partnership with Motion Sickness (Auckland) and FINCH (Sydney), represents a paradigm shift in public health communications, demonstrating how bold creative strategies can effectively address sensitive health topics and drive measurable behaviour change within healthcare communities and the broader public.
Launched in October 2024 on Global Herpes Awareness Day, the campaign successfully challenged decades of entrenched stigma surrounding genital herpes – a condition that affects up to 80% of New Zealanders at some point in their lives. Through innovative use of humour, gamification, and celebrity endorsement, the initiative transformed a traditionally taboo medical topic into an accessible national conversation.
The campaign's 'Herpes Destigmatisation Course' featured prominent New Zealand figures including Sir Ashley Bloomfield and Sir Graham Henry delivering evidence-based health education through engaging video content. A Herpes Stigma Index provided real-time global rankings, encouraging community participation and measuring progress against international benchmarks.
Within eight weeks, New Zealand rose from ninth to first place on the global stigma index. The campaign generated exceptional engagement metrics including:
Over 10,700 hours of educational content consumed
12.7 million impressions across social channels
69% of participants reported reduced stigma attitudes
86% felt more comfortable discussing herpes openly
81% expressed motivation to support others with HSV
The campaign's success underscores the critical importance of addressing the substantial gap between medical reality and public perception of HSV. While most people (~80%) will host a Herpes Simplex Virus during their lifetime, only approximately 20% will experience recognisable symptoms. The majority remain undiagnosed because most people who host herpes simplex don't experience symptoms ( ie are asymptomatic ) creating ongoing challenges for clinical management and patient counselling.
'This campaign demonstrates the transformative power of exceptional creative communications in achieving public health outcomes that traditional medical education approaches have struggled to deliver,' said NZHF Trustee Alaina Luxmoore. 'We're immensely proud that our bold approach to destigmatising herpes has resonated not only in New Zealand but globally. The message we're conveying is simple – herpes is a common, manageable virus that doesn't define a person's worth or relationships.
'Winning the Cannes Lions Grand Prix for Good validates our belief that innovative communications can break down barriers that have prevented effective clinical care and patient wellbeing for decades. However, this recognition is just the beginning. While we're officially the best place in the world to have herpes, maintaining this title requires constant education, ongoing destigmatisation efforts, and continued advancement in clinical training on best-practice herpes management and treatment guidelines. We're committed to building on this momentum to ensure healthcare providers and patients alike have access to evidence-based, stigma-free herpes care.'
The campaign's international acclaim extends beyond Cannes Lions, with awards from AdFest 2025 (Gold Lotus – Entertainment), Clio Health 2025 (multiple Gold and Silver awards), D&AD (Wood Pencils), and The One Show (Bronze – Health & Wellness). This recognition highlights the campaign's effectiveness as a model for addressing sensitive health topics through creative communications.
David Ohana, Chief Communications & Marketing Officer at the United Nations Foundation and Cannes Lions jury president, praised the campaign: 'This year's Lions Health Grand Prix for Good unabashedly uses humour to tackle a challenging subject and stigmatisation. Our 2025 awardee took a taboo topic and turned it on its head – showing that with a great strategy, a big, bold crazy idea, and humour for days, that anything is possible.'
The campaign's success provides valuable insights for healthcare professionals addressing HSV in clinical practice. By normalising conversations about herpes and emphasising that HSV-1 and HSV-2 are essentially the same virus managed through identical clinical approaches, the initiative supports more effective patient counselling and care delivery.
For healthcare providers, the campaign reinforces that societal conditioning around herpes requires recalibration. HSV-1 causes approximately 50% of genital herpes cases, often through oral-to-genital contact, yet remains socially acceptable when presenting as oral cold sores while carrying significant stigma in genital presentations.
The Foundation's ongoing work will focus on supporting clinical education initiatives, advancing diagnostic understanding, and promoting evidence-based treatment guidelines. With no definitive diagnostic test available for asymptomatic individuals, the campaign's emphasis on reducing stigma becomes even more critical for effective public health management.
The New Zealand Herpes Foundation is dedicated to providing accurate information, support, and advocacy for individuals affected by Herpes Simplex Virus. Through evidence-based education and innovative communications strategies, NZHF works to eliminate stigma and improve health outcomes for all New Zealanders. This includes running a herpes helpline managed by nurse counsellors. The helpline can be reached on 0508 11 12 13 from a landline or 09 433 6526 from a mobile. For more information on the helpline and NZHF's other services visit: herpes.org.nz.
The 'Make New Zealand the Best Place in the World to Have Herpes' campaign was supported by Sexually Transmitted Infections Education Foundation, Whānau Ora and Sexual Wellbeing Aotearoa.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NZ Herald
9 hours ago
- NZ Herald
Cancer charity Look Good Feel Better gets a wellbeing-focused makeover
For more than 30 years, Look Good Feel Better has been supporting New Zealanders who have cancer. With backing from the cosmetics industry, the charity is best known for its makeover skincare and make-up classes, and has mostly focused on helping women navigate the changes in their appearance caused by
NZ Herald
11 hours ago
- NZ Herald
Hawke's Bay runner Nicole Pendreigh plans marathon for 115 women killed on runs
'Running has become a source of strength and healing for me. But for many women, it's also a source of fear,' she told the Herald. This race is a challenge she was once told she would never be able to do after a serious hip injury meant she could only run 30 seconds at a time. Nicole Pendreigh, a 23-year-old runner from Hawke's Bay, plans to finish a marathon in Taupō on August 2. Photo / Supplied From injury to marathon-ready In 2022, Pendreigh fractured her hip and suffered a labral tear, leading to years of pain after her injury was initially misdiagnosed as a groin strain. 'I didn't get any scans done. I was kind of doing the wrong sort of rehab for it, which led to an impingement,' she said. 'There was extra bone growth on my femur, which causes my bones to rub together on my hip.' Her hip capsule was inflamed and had become thickened. 'I tried to get cortisone injections for it because I couldn't sit for over an hour. 'I couldn't walk uphill or downhill. I couldn't sit on the ground without pain.' Pendreigh said she was told to give up running and look for another hobby because it was 'just something I'll have to deal with now'. At the beginning, she was only able to run for short distances and could only manage 30-second blocks. After years of rehab, Pendreigh has built up her body's tolerance for running. 'I think later on it might give me a bit of grief, but it's definitely worth it for the [marathon] day.' 'Constantly getting scared' Pendreigh said the run will be about more than just crossing the finish line. 'It's about honouring the lives of women lost and working toward a future where every woman can run freely and safely.' Pendreigh said because of her schedule and the winter season she is forced to run at night or early morning in the dark. 'I'm constantly getting scared from my own shadow ... and people or males coming towards me.' She told the Herald she was on a daytime beach run when an incident with a man occurred that sparked her desire for change. 'I was running, and he thought it was a fun time to just yell at me, and he started running after me, which was super scary,' she said. 'It got me thinking about how unsafe women feel when running and how normal it is for me to feel like that on a run. 'I wanted to make it not normal.' Women assaulted and killed on runs Pendreigh said she will be dedicating her marathon to 115 women killed on runs worldwide, including murdered Kiwi runners Jo Pert and Margaret-Lynne Baxter. The young athlete will be wearing a custom top with all 115 names. 'I'll bring all of them across the line. I've got all 115 names on the back of my top and two of them are New Zealanders as well.' Nicole Pendreigh plans to tackle a marathon event wearing a top bearing the names of 115 women killed on runs worldwide. Photo / Supplied Wellington resident Margaret-Lynne Baxter was run down, abducted, raped and murdered near the Hastings suburb of Flaxmere during a Sunday morning run in 2001. In 2016, mother-of-two Jo Pert died after being attacked while out jogging in Remuera, Auckland. 'I really want to have them along with me in the journey,' Pendreigh said. 'Just knowing that they were trying to do something for enjoyment and got their lives taken because of it.' Sign up to The Daily H, a free newsletter curated by our editors and delivered straight to your inbox every weekday.
Scoop
3 days ago
- Scoop
17,096 Kiwis Call For Urgent Action To Fund Keytruda For New Zealand's 'deadliest Breast Cancer'
Breast Cancer Foundation NZ is proud to support Auckland woman, Catherine Cooke, as she presents her petition to MP Hon. Mark Mitchell, urging the Government to fund the cancer drug Keytruda for early stage triple negative breast cancer (TNBC). Catherine is presenting the petition at Breast Cancer Foundation NZ office in Parnell on 27 June at 2pm. The level of support for this petition is significant and shows New Zealanders are fed up with falling behind the rest of the world in terms of access to life-saving treatment. Catherine was diagnosed with early TNBC, an aggressive form of breast cancer in November last year after her yearly mammogram. She was told Keytruda with chemotherapy would give her the best chance of survival – but the drug would only be funded if her cancer was advanced. Instead, Catherine has had to put most of her work on hold and sell her family home to fund the treatment - which is costing around $85,000. Around 350 women are diagnosed with triple negative breast cancer every year, which is approximately 10% of all breast cancer diagnoses. It is also more common in younger women with nearly 15% of diagnoses in women under the age of 45 being triple negative. For one in three women with early triple negative breast cancer, it will return and become incurable within five years. It is the deadliest form of breast cancer and is harder to treat. Unlike most other breast cancers, triple negative breast cancer doesn't respond to hormone-blocking treatments and targeted drugs. Keytruda is an immunotherapy drug, and it is the only targeted treatment that works to fight triple negative breast cancer and is given to patients alongside chemotherapy. It's fully funded in 40 other countries including Australia, Canada and Britain. New international research was published last year and showed that Keytruda can stop women dying from triple negative breast cancer because it's highly effective at preventing cancer coming back. Patients with early triple negative breast cancer receiving Keytruda in a clinical trial were 34% less likely to die and 32% less likely to have their cancer spread beyond the breast. It is widely accepted by the medical community internationally as the best drug to treat early triple negative breast cancer and New Zealanders deserve access to this treatment. Breast Cancer Foundation NZ Chief Executive, Ah-Leen Rayner said 'women like Catherine are having to go through drastic lengths to be able to pay for Keytruda. It's atrocious that New Zealanders are selling their homes, asking for help from their parents or complete strangers to find hundreds of thousands of dollars, or potentially simply going without treatment that could save their lives. 'We are so grateful to Catherine for working tirelessly for better drug access for New Zealanders in the future, but she shouldn't have to. We're urging the government to ensure Pharmac has the budget it needs to fund these essential medicines that are standard of care around the world.'
